Extract to table
Pull the structured facts out of a document: parties, dates, amounts, obligations.
Extract to table / officer-certificate-penterra.docx
officer-certificate-penterra.docx
Parties
Penterra Pharmaceuticals Corp
Good Standing Penterra Pharmaceuticals Corp
Callahan LLP
Dates
June 28, 2023
July 5, 2023
March 15, 2019
June 22, 2023
September 12, 2005
May 30, 2023
April 1, 2023
March 31, 2024
March 31, 2023
December 31, 2022
Amounts
$80,000,000
$52,000
$1,500,000
$25,000,000
$75,000,000
$10,000,000
$50,000,000
$890,000,000
$1,870,000,000
$612,000,000
Obligations
Capitalized terms used but not otherwise defined in this Certificate shall have the meanings ascribed to such terms in the MCTA, including its exhibits, schedules, and appendices
Specifically, Penterra confirms the following: (a) Penterra shall indemnify, defend, and hold harmless Veridian Health Research Network, Inc
(c) The indemnification obligation with respect to product-defect claims, as described in clause (a)(ii) above, shall be uncapped, meaning that there shall be no maximum limit on Penterra's liability for losses arising from defects in the investigational product
Failure to provide timely notice shall not relieve Penterra of its indemnification obligations except to the extent that Penterra is materially prejudiced by such failure
The foregoing indemnification obligations remain in full force and effect as of the date hereof and shall continue in accordance with the terms of the MCTA, including the survival provisions set forth in Section 11
This Certificate is an integral part of the closing deliverables contemplated by the MCTA and shall be construed in accordance with and subject to the terms and provisions of the MCTA